NCT01989572
Clinical Trial Information
Trial Number: NCT01989572 (ClinicalTrials.gov)
Disease Type:
- Skin Neoplasm - Melanoma
Trial Title:
A Randomized, Placebo-Controlled Phase III Trial of Yeast Derived GM-CSF Versus Peptide Vaccination Versus GM-CSF Plus Peptide Vaccination Versus Placebo in Patients With No Evidence of Disease After Complete Surgical Resection of Locally Advanced and/or Stage IV Melanoma
Study ID:
E4697
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT01989572-D2 | There are two different submissions (each with one dataset) for trial NCT01989572. This dataset, NCT01989572-D2, contains toxicity data. The other dataset, NCT01989572-D1, contains baseline and efficacy data. |
| NCT01989572-D1 | There are two different submissions (each with one dataset) for trial NCT01989572. This dataset, NCT01989572-D1, contains baseline and efficacy data. The second dataset, NCT01989572-D2, contains toxicity data. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®